Bronchiolitis obliterans syndrome (BOS) is the major limitation to survival after lung
transplantation. Acute rejection, its main risk factor, is characterized by perivascular …

Bronchiolitis obliterans syndrome (BOS) is the major limitation to survival post-lung
transplantation and is characterized by a persistent peribronchiolar inflammation that …

Lung transplantation remains the only effective therapy for patients with end-stage lung
disease, but survival is limited by the development of obliterative bronchiolitis (OB). The …

Acute allograft rejection is a major complication postlung transplantation and is the main risk
factor for the development of bronchiolitis obliterans syndrome. Acute rejection is …

Lung transplantation is a therapeutic modality frequently used in end-stage lung disease.
Unfortunately, lung transplant recipients have poor clinical outcomes, often due to the …

Angiogenesis and vascular remodeling support fibroproliferative processes; however, no
study has addressed the importance of angiogenesis during fibro-obliteration of the allograft …

Obliterative bronchiolitis (OB) post-lung transplantation involves IL-17–regulated
autoimmunity to type V collagen and alloimmunity, which could be enhanced by …

BACKGROUND:: The early stage of post-transplant obliterative bronchiolitis (OB) is
characterized by an influx of inflammatory cells to the lung, among which neutrophils may …

Bronchiolitis obliterans syndrome (BOS) is a condition of progressive airflow obstruction that
affects a majority of lung transplant recipients and limits long-term posttransplant survival …

Bronchiolitis obliterans syndrome (BOS) is a major impediment to lung transplant survival
and is generally resistant to medical therapy. Extracorporeal photophoresis (ECP) is an …